top of page

The new cannabinoids - PHC!

PHC (Phyto-Cannabinoids) a cannabinoid composition
to achieve similar properties to THC.
The legal alternative to HHC and THC
Effective and powerful!

The PHC flower varieties are listed in the European Union variety catalogue
and therefore for the Legal hemp cultivation in the EU permitted with less than 0.3% THC
Aroma products - laboratory certified - without pesticides and pollutants.

  • What is H4CBD?
    H4CBD is a brand new cannabinoid on the market. It is made from CBD and is said to be up to 100 times more potent on CB1 receptors than CBD. H4CBD is not a derivative of HHC or THC and is therefore described as the legal alternative to THC.
  • What is the difference between H4CBD and HHC?
    Both come from the hemp plant. However, H4CBD and HHC are different. H4CBD is a hydrogenated form of CBD. HHC, however, is a hydrogenated form of THC. Hydrogenation is a chemical process, an example of which is the production of margarine, but the process is also used in the production of H4CBD. In simpler terms, additional hydrogen atoms are attached to a starting material. In the case of H4CBD, the starting material is the cannabinoid CBD. H4CBD is believed to exhibit greater activity at the CB1 receptors than CBD.
  • Which is better, H4CBD or CBD?
    Scientists in Todd's group have known about H4CBD since the 1940s, but it's only recently that this hydrogenated form of CBD has come into the spotlight. As CBD has reached incredible levels of popularity that no one would have previously imagined possible, the demand for more alternatives that may offer even better benefits has increased tremendously. Furthermore, in 2006, scientists discovered that H4CBD has a binding affinity to the CB1 receptor and that H4CBD has stronger anti-inflammatory biomarkers than conventional CBD. Simply a stronger CBD in certain areas. Rather than thinking of H4CBD and CBD as rivals, consider the advantages of each: CBD could be the weaker, all-natural option, while H4CBD would serve as a more optimized, stronger alternative. As modern cannabinoid research continues to advance rapidly, both CBD and H4CBD will surely play central roles.
  • Does H4CBD make you high?
    In general, CBD has a lower affinity for the CB1 receptors. The CB1 receptor mediates the effects of endogenous cannabinoids as well as exogenously administered cannabinoids in the central nervous system and is therefore a component of the endocannabinoid system. You can find out more about this in our blog post. However, in combination with four hydrogen atoms (hence the name H4CBD), the affinity of CBD to the CB1 receptors apparently increases considerably, making the new cannabinoid H4CBD more psychoactive. H4CBD has a 100-fold greater binding affinity for the human CB1 receptor (Ki = 145 nm) than CBD (Ki = >10 µm), putting it in the same range as CBN in terms of its psychoactive potential, perhaps slightly stronger. Although H4CBD is 100 times more psychoactive than CBD, its psychoactive properties are still less than THC and HHC.
  • Is H4CBD legal?
    Products containing fully hydrogenated H4CBD have a low and undetectable THC content. Therefore, it is legal in all countries where CBD is legal.
  • Sources and references
    Ben-Shabat, S., Hanuš, L.O., Katzavian, G., & Gallily, R. (2006, January 6). New cannabidiol derivatives: synthesis, binding to cannabinoid receptors, and evaluation of their anti-inflammatory activity. Journal of Medicinal Chemistry, 49(3), 1113–1117. Retrieved from https://pubs.acs.org/doi/10.1021/jm050709m Laprairie, RB, Bagher, AM, Kelly, MEM, & Denovan-Wright, EM (2015, October). Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. British Journal of Pharmacology, 172(20), 4790–4805. Retrieved from https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.13250 Morales, P., Reggio, PH, & Jagerovic, N. (2017, June 28). A review of the medicinal chemistry of synthetic and natural derivatives of cannabidiol. Frontiers in Pharmacology, 8. Retrieved from https://www.frontiersin.org/articles/10.3389/fphar.2017.00422/full

Click here to see our
CBN products

Sale only to persons aged 18 and over!
By completing your order you confirm
that they are older than 18 years.

All our flowers are aroma products.
Our products come exclusively
of certified seeds that are
“Common Catalogue of Varieties of the EU”.
Product names are for marketing purposes.
Exploitation and further processing prohibited.
The products (flowers, pollinates) are quality tested, certified
and come from Austria, the EU and Switzerland.
The hemp plants grow in compliance with strict EU regulations.
Legal in Austria with less than 0.3% THC.

The changing cannabis industry: health and legal aspects

The discussion about the possession and consumption of cannabis and cannabis products has become more intense in recent years. There is increasing acceptance and demand, particularly in countries where the possession and consumption of legal cannabis is permitted. A crucial point in this debate is the role of Health Minister Johannes Rauch (Greens), who advocates regulated release and strict controls.

Another current topic is the substance hexahydrocannabinol (HHC), a psychoactive compound that is gaining increasing attention. This substance is often marketed as a legal high because it does not clearly fall under existing substance laws in some regions. HHC is often produced synthetically, which means that HHC products are extracted in laboratories and not directly from the cannabis plant.

It is important to note that HHC products are classified as a psychoactive substance and can therefore pose similar risks to other psychoactive substances. The market for synthetically produced HHC products is growing rapidly, which underlines the need for clear legal regulations and controls.

The production and trade of these products raises questions, particularly regarding quality and safety. A regulated market for legal cannabis and related products could help provide better protection for consumers and curb the black market.

Finally, it remains to be seen how the legal framework will develop worldwide. The efforts of politicians like Johannes Rauch could be crucial for how the production and trade of cannabis products are regulated in the future. This would not only have an impact on health and drug policy, but also on society's approach to cannabis and its derivatives.

bottom of page